Clinical Trials Browser

Phase 3 × bintrafusp alfa protein, human × 90 days × Clear all

NCT05061823 2026-02-02

Bintrafusp Alfa Program Rollover Study

Phase 3 Completed

22 enrolled 11 charts

Lung Neoplasms, Neoplasms